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ABSTRACT 
 
 
Introduction: Endometrial cancer is a gynaecological cancer that mostly affects women 
in their sixth and seventh decades of life. It is the fourth most common malignancy in 
women and ranks eighth among all causes of female cancer in terms of age-adjusted 
mortality. In developed and numerous developing countries endometrial cancer, as well 
as other types of cancer in women, is an ever-increasing threat that may be explained, 
among other reasons, by increased life expectancy and a reduction in fertility or birth 
rates. Conversely, in South Africa and most other African countries, the previous 
reasons do not exist, because there is a decline in life expectancy due to increased HIV, 
low income, and a high fertility rate. International epidemiological studies have 
established significant relationships between endometrial cancer and risk factors such 
as the woman’s age, race, early menarche and late menopause, parity, a history of 
breast or ovarian cancer, the use of endogenous estrogens, concomitant diabetes, 
family history of breast and ovarian cancer, estrogen therapy, obesity, and the use of 
tamoxifen. The aim of the study was to identify risk factors associated with endometrial 
cancer among black South African women. 
 
Method: The present case control study comprised black South African women 
diagnosed with a cancer in Johannesburg, between 1995 and 2005. The study included 
592 women aged 27 to 90 years who were admitted to three main public hospitals in the 
city of Johannesburg with histologically confirmed cancers. 148 cases with endometrial 
cancer and 444 women with other forms of cancer were analysed. Only newly occurring 
cases (incident) were included. Women in the control group consisted of those with 
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cancers not associated with reproductive or hormonal factors, i.e. not cancers of the 
breast or the female reproductive system. Data handling, cleaning and analysis were 
done using Stata 9 (STATA). 
 
Results: Univariate analysis showed that the risk for endometrial cancer was 
significantly (P<0.05) affected by: miscarriages, the place of former residence, place of 
current residence, the use of snuff, wine consumption, age of the youngest child, 
diabetes, age of menarche, age of menopause, and menstrual status. Smoking was 
found to be a protective factor for endometrial cancer compared to other cancers. After 
multivariate adjustment, endometrial cancer risk was significantly (P<0, 05) associated 
with miscarriages, age at menarche, and earlier completion of childbearing. Smoking 
remained a protective factor against endometrial cancer. 
 
Conclusion: The current study reports similar results to those observed in other 
international investigations. The risk of endometrial cancer was higher among women 
who were older, women who experienced miscarriages, and those who fell pregnant 
early in their reproductive lives. Smoking was a protective factor against endometrial 
cancer compared to other cancers. However, comparing the cases of endometrial 
cancer with smoking-associated cancer controls (i.e. lung cancer, oesophageal cancer, 
and mouth cancer) might have distorted the results. A more appropriate control group 
for confirming the relationship between smoking and endometrial cancer would be 
subjects with no cancer. Also, it will be important to evaluate the risk factors for cancer 
among the other race groups in South Africa. 
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1.1. Introduction 
 
Endometrial cancer is a cancer that starts in the endometrium, the inner lining of 
the uterus. It is one of the most common cancers in women; ranking fourth 
among incident cancers in women, and eighth in terms of age-adjusted mortality 
(1). Although it has a comparatively low mortality rate compared with other 
gynaecological cancers, it is capable of aggressive behaviour. Despite the 
previous facts, endometrial cancer is a disease in which 85% of patients can be 
cured. It has been estimated that the prevalence of endometrial cancer is about 
0.01% in most developed countries (1). It is primarily a disease of 
postmenopausal women, and affected women typically present with 
postmenopausal vaginal bleeding, resulting in earlier diagnosis than for most 
other gynecologic malignancies (2). Because of this fact, there is no support for 
the screening of asymptomatic women, and some evidence against the benefit of 
screening (3). The disease manifests at an average age of 55, a full decade later 
than cervical cancer, and is traditionally considered a disease of the sixth and 
seventh decades of life (4). 
 
Endometrial cancer develops when the cells that make up the inner lining of the 
uterus (the endometrium) become abnormal and grow uncontrollably (5, 6). 
Endometrial cancer represents more than 95% of the uterine cancer. The most 
common type of uterine cancer is adenocarcinoma (7). It arises from an 
abnormal multiplication of endometrial cells (atypical adenomatous hyperplasia) 
and is made up of mature, specialized cells (well-differentiated). It is very rare 
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that endometrial cancer occurs without a preceding hyperplasia and is made up 
of poorly differentiated cells. The more common of these types are the papillary 
serous and clear cell carcinomas. Poorly differentiated endometrial cancers are 
often associated with a less promising prognosis (2). 
Endometrial cancer remains the gynecologic malignant disease with the highest 
annual prevalence in the Northern America and part of Europe. The causes of 
endometrial cancer are unknown, but some factors like; early menarche and late 
menopause, miscarriages, nullparity, history of breast or ovarian cancer, the use 
of endogenous estrogens, concomitant diabetes, hypertension, and obesity have 
been found to increase endometrial cancer risk. The study question, for the 
current study, is what are the risk factors related to endometrial cancer in Black 
South African women. Specifically, whether early menarche, late menopause, 
nulliparity, miscarriages, age at first and last birth, the use of endogenous 
estrogens, diabetes, hypertension, HIV-AIDS, and other socioeconomic factors 
are risk factors for endometrial cancer in Black South African women 
 
 
1.2. Problem statement  
 
The Black population represents the majority of South African society (more than 
75% of the total population) and like other races was marginilised during the 
apartheid regime. This marginilisation has created gaps in the existing 
information regarding many public health issues with endometrial cancer being 
one of them. In 1994, an extensive case control study was started to look at 
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different types of cancer in the Black population in the city of Johannesburg. 
Increasing prevalence of endometrial cancer in westernised countries, has led 
researchers in these countries to identify risk factors for the development of this 
cancer. Changing lifestyles in the South African society generally and in the black 
population specifically could create new risk factors that may increase the 
prevalence of diseases like endometrial cancer. Thus endometrial cancer is 
clearly an important health problem in the Black population that needs to be dealt 
with appropriately to sustain public health advances that have already been 
achieved.  
 
1.3. Significance of the study  
 
This study will enable us to highlight the risk factors associated with endometrial 
cancer in black women in South Africa. Understanding these risk factors will give 
us an idea as to which of these are preventable, and thus reduce the risk of black 
women getting endometrial cancer. By classifying the women with endometrial 
cancer according to age, we will be able to identify at which age black women get 
diagnosed most often with endometrial cancer. This may help the country to 
develop programme that would create awareness of endometrial cancer in 
different age groups, thereby resulting in possible earlier diagnosis and the 
increase in survival. Also this may increase the survival among black women 
specifically and women who belong to other races generally. This study may 
increase awareness of the disease in the black population. Finally, it will be also 
a good opportunity for the country to monitor cancers by population groups. 
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2.1. Incidence of Endometrial Cancer  
 
Endometrial cancer is the most common gynaecological cancer usually affecting 
women in the post-menopausal age group. The average age at diagnosis differs 
from country to country but is usually 55-65 years in most countries. Similarly, the 
peak endometrial cancer incidence also fluctuated between countries, but the 
limit is between the ages of 70 and 74. Endometrial cancer comes fourth among 
incident cancers in women, and eighth in terms of age-adjusted mortality. 
Although 90% of women with endometrial cancer present with abnormal uterine 
bleeding and nearly 75% of women present with early stage disease, the death 
rate due to this cancer has increased over 100% during the past 20 years (8). 
Endometrial cancer represents almost 2% of all cancer incidence (around 4% in 
women), and accounts for approximately 1% of all cancer deaths (nearly 2% in 
women) (9).   
The incidence of endometrial cancer increases after menopause and continues 
to increase with increasing age especially when there is an exposure to 
unopposed oestrogen including hormone replacement therapy. It has been 
reported that approximately 85% of cases are diagnosed in postmenopausal 
patients (10). The average age at diagnosis differs from country to country but is 
about 60 years or older in most countries (6). Endometrial cancer is mainly a 
disease of high-income countries, where overall rates are nearly five times higher 
than rates in middle to low income countries. The incidence of endometrial 
cancer is about 10 times higher in developed countries than in Asia and Africa 
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(11).  Age adjusted rates of endometrial cancer are increasing in countries 
undergoing transition from low-to high income economies, although there is no 
clear, overall trend in high-income countries (12,13). 
In South Africa, the incidences rates of uterine cancer are two fold lower 
compared to incidence rates reported in developed countries (figure 2-1) and, are 
two fold higher than in developing countries (14). Endometrial cancer ranks 14th 
and considered to be the most prevalent of all cancers in the total population. 
According to the South African cancer registry reports, 1996-1997 and 1998-99, 
Asian females had the highest incidence rate of endometrial cancer. Endometrial 
cancer was the third and the fourth leading cancer among Asian females in 1996 
and 1997 respectively, and a similar trend has been found in 1998-1999. In Black 
females, it is ranked the fourth leading cancer (figure 2-2). The lifetime risk of 
developing this cancer in Asian females was about 1 in 87 in 1997, while in black 
women it was 1 in 189 (15). Unfortunately, there is no other information 
describing the distribution of incidence rate of endometrial cancer with age in 
Black South African women, nor there similar data regarding other races. 
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Figure (2-1) Age standardized incidence rate for uterus cancer per 100 000 for 
selected countries from 1995-2000. (14) 
 
Endometrial cancer is considered to be the most common invasive 
gynaecological cancer in Northern America, and part of Europe. The range of the 
incidence of the disease (after adjusting for age) fluctuates from 15 per 100 000 
women in North America and Northern Europe to less than 5 per 100 000 in most 
of Africa and Asia. However, the risk of the disease has been shown to increase 
in Asian and African emigrants to developed countries, possibly due to changes 
in environmental risk factors (14). The wide difference in the incidence of 
endometrial cancer across the world (figure 2-1) may be explained by differences 
in the distribution of known and unknown risk factors of the disease.  
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It has been estimated that in a country like the USA there were, 40.100 new 
cases of endometrial cancer diagnosed in 2008 and 7470 women had died from 
the disease in that year(16). According to the National Cancer Institute, in the 
USA, the death rate from endometrial cancer fell more than 50% from 1950-1970 
and has continued to decline, due in large part to earlier diagnosis and more 
effective treatment. Though the incidence of endometrial cancer rose rapidly 
briefly in the 1970s, presumably due to the increased use of menopausal 
oestrogen therapy, it has since stabilised (17).  
Studies in the USA have consistently shown that black women have a lower 
overall incidence (51%) of endometrial cancer than white women (75%) (13), but 
are diagnosed with later-stage disease, have shorter survival, and have the 
highest mortality from endometrial cancer of all ethnic groups in the USA. These 
observations may not necessarily be indicative of differences in ethnicity only 
rather late detection and advanced staging of endometrial cancer in black women 
led to the observed higher mortality rates (18, 19, 20). 
Lower socioeconomic status and greater clinical co-morbidity have also been 
found to contribute to poor outcomes among African-American women in some 
studies (21, 22). These factors lead to delayed diagnosis, differential treatment 
and ultimately may contribute to racial differences in endometrial cancer survival. 
During the nineteenth century, the chances of 5-years survival for African 
American women with endometrial cancer were 58.9%, 66.67% for Hawaiian and 
85.8% for white women (23). The overall 5-years survival rate was found to be 
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lower in middle- than in high-income countries (67% compared with 82%) (24, 
25). The lower survival rate among African American and Hawaiian women with 
endometrial cancer as compared to Caucasian women suggests that access to 
health care may be an issue. It is very likely that endometrial cancer in white 
women is diagnosed at an earlier stage and is thus easier to treat (26). Death 
rate may increase due to the treatment of other types of cancers, like use of 
surgical resection for early-stage lung cancer, radical prostatectomy for localised 
prostate cancer, and radiation therapy for localised breast cancer (26, 27).  
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Figure (2-2) Leading cancers in Black South African females (15) 
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2.2. Anatomy of the Uterus  
The uterus is a muscular hollow organ, upside-down, pear-shaped, that is 
located in a woman's pelvis behind the bladder and in front of the rectum, and 
has two main parts. The lower end of the uterus, which extends into the vagina, 
is called the cervix. The upper part is the body of the uterus, also known as the 
corpus (figure 2-3). The body of the uterus has two layers the outer which is a 
thick muscular wall called the myometrium and helps the mother to push the 
baby out during birth and an inner lining  which is very sensitive to hormones and 
it changes daily during the menstrual cycle and called the endometrium. The 
inner layer is designed to provide an ideal environment for implantation and 
growing of the fertilized egg. If pregnancy does not occur, the endometrium is 
shed causing the menstrual period (28). 
The changing thickness of the endometrial is highly dependent on the secretion 
of estrogen and progesterone. Estrogen causes cellular growth and is an 
important component of the rebuilding, follicular phase of the menstrual cycle. 
Progesterone is secreted during the later, thick-walled luteal phase, and it 
balances out the effects of the estrogen. Abnormal growth of endometrial cells 
(whether cancerous or not) and endometrial cancer are believed to be due to 
chronic exposure to too much estrogen without the balancing effect (28). 
Table 6 in the appendix displays FIGO Surgical Stages for Endometrial Cancer, 
which considered world widely in identifying the stage of the disease 
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Figure 2-3 Comparison in female reproductive system between healthy women –
up- and woman with endometrial cancer-down- (28). 
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2.3. Risk Factors for Endometrial Cancer 
 
Risk factors for endometrial cancer have been well defined in western countries. 
The risk of the disease increases with age and family history of endometrial 
cancer, particularly among close relatives. Infertility is highly associated with 
endometrial carcinoma, particularly in the presence of polycystic ovarian 
syndrome, which is linked with the development of premenopausal endometrial 
cancer (2). Long-term use of unopposed oestrogens for hormone replacement 
therapy also increases the risk of endometrial cancer. Although prescribing 
oestrogens alone is now uncommon, women with an intact uterus can still be 
prescribed unopposed oestrogens, increasing their risk of developing 
endometrial cancer six fold (2). 
Despite the fact that certain risk factors are more common in women who get 
endometrial cancer, researchers in this f ield found that the impact of 
these factors differs in various populations.  Almost 70% of endometrial 
cancers are reported in women who have no documented risk factors-such as 
those that might disorder endocrine processes (29). International epidemiological 
studies have established the following risk factors to be related with endometrial 
cancer: 
2.3.1. Age 
 
Increasing age plays an important role in endometrial cancer, as well as with 
other female-specific cancers, such as breast, cervical, and vaginal cancer. 
Endometrial cancer is more common in menopausal women than in 
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premenopausal women (30) and the lifetime risk of the disease increased with 
age reaching 40% at age 70 (31). 
 
2.3.2. Race 
Studies have shown that white women have a higher risk of developing 
endometrial cancer than women of other racial groups. Setiawan and colleagues 
showed that the risk of endometrial cancer in white Americans far exceeded that 
in African Americans, Native Hawaiians, Japanese Americans, and Latinas (32).   
Nevertheless, the mortality rate from endometrial cancer among black women in 
the USA is 79% higher than the mortality rate in white women (33). These 
differences in mortality rate can be partially explained due to the stage at 
diagnosis, where 40% of the survival difference is attributable to African 
American women presenting with more advanced-stage disease.  
2.3.3. Geographical and Socioeconomic factors  
In general, the incidence of cancer may significantly differ from country to country 
or from area to another area in the same country, or state. Differences in lifestyle 
and socioeconomic are exist not only among countries but also among races (11, 
12, 13). The socioeconomic gradient in cancer risk generally tends to affect 
women in different ways. It found to be positive (richer women are more affected 
than their poorer counterpart) for skin melanoma and cancers of the colon, 
breast, and ovaries, whereas negative association has been observed (i.e., 
poorer women are more affected than their richer counterpart) for lung, stomach, 
esophagus, and cervical cancer (34) 
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2.3.3.1. Place of birth & Place of residence  
As people moving from place to another during their life time, this may 
underestimate the previous risk factors. However, most other studies, found no 
significant relationship between place where a woman was born or place of 
residence and the risk of endometrial cancer (35). 
    
2.3.3.2. Education level  
Although, education is found to be inversely associated with the incidence of 
most cancers, especially those related to smoking (36, 37), however it is relation 
with endometrial cancer still controversial. Educated women are usually cautious 
about the risk factors of diseases, but some risk factors of disease like female 
cancer are found in epidemiological to have a positive correlation. Educated 
women get an excess to oestrogen replacement, which related to the 
development of endometrial cancer. Also, educated women get better access to 
medical care and therefore, they early diagnosed, while uneducated women, 
even though they get the disease, they may died with out seeking medical care 
(38). 
 
2.3.3.3. Smoking  
 Although smoking is consider to be a risk factor for many kinds of cancers, the 
case with endometrial cancer seems different. Many studies have reported, that 
smoking is a protective factor against endometrial cancer in premenopausal and 
post menopausal women (39, 40, 41). The risk of endometrial cancer had 
declined dramatically, with increased duration of smoking (39, 41, 96, 98). 
Smoking considers having anti-estrogenic effect (42, 43). Many studies have 
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shown that the risk of endometrial cancer has decreased significantly in women 
who smoke (41) and the risk continued to decrease with increased duration of 
smoking (39, 41). However, the latter relationship was only found to exist in 
postmenopausal women (39, 41). 
 
The association between smoking and endometrial cancer risk may be attributed 
to anti- estrogenic effect of smoking (42, 43). Thus, Smokers have lower 
endogenous estrogen levels compared to nonsmokers (44, 45), and because 
estrogen promotes the progress of endometrial cancer, their chances of 
developing the disease decreased compared to non-smokers (44, 45). Smoking 
also reduced the effect of oestrogen by reducing the age of menopause, so that 
smokers  has less menstrual cycles compared non-smokers (46). 
 
2.3.4. Early Menarche & Late Menopause 
Women who start menstruating early in life or who have a late menopause have 
an increased risk of developing endometrial cancer (47, 48). Similarly, an 
increased number of menstrual cycles during a woman’s lifetime raise her risk of 
endometrial cancer, due to the high exposure to estrogen. Women whose 
menopause occurred after the age of 50 years had a 67% elevated risk of 
endometrial cancer compared with women whose menopause occurred before 
the age of 45 years. This risk increased to 79% when menopause occurred after 
the age of 55 years (33). 
 
17 
 
2.3.5. Family history 
Studies reported a small increase in the risk of endometrial cancer (5%) 
associated with a family history of the disease (49), especially among first degree 
relatives (50, 51). Studies have found that family history of endometrial cancer is 
associated with a higher risk of the disease in premenopausal women (51, 52). 
Some of these families also have an inherited tendency to develop a type of 
colon cancer called hereditary non-polyposis colon cancer (HNPCC) (53). Family 
history of cancer is another independent risk factor for endometrial cancer (51). 
Studies have reported an increase in the number of young women with 
endometrial cancer who have a family history of cancer (not necessarily 
endometrial cancer), suggesting a genetic link (54, 55).  
 
2.3.6. History of breast or ovarian cancer 
Women who have had breast or ovarian cancer may have an increased risk of 
developing endometrial cancer. Some of the dietary, hormonal, and reproductive 
risk factors for breast and ovarian cancer also increase the endometrial cancer 
risk.  Beiner and colleagues (56) found a 5.3-fold elevated risk of endometrial 
cancer in women carrying a deleterious mutation in the BRCA1 gene that were 
treated with tamoxifen for previous breast cancer. In another study carried out on 
mutation-positive families in Western Europe and North America, the Breast 
Cancer Linkage Consortium found a 2.7-fold increase in relative risk of 
endometrial cancer in BRCA1 mutation carriers (57) but no increased risk for 
BRCA2 mutation carriers (58). 
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2.3.7. History of Infertility 
Early loss of ovarian function is not only associated with loss of fertility but also 
puts the patients at risk for endometrial cancer at a very young age. In recent 
years there has been an exponential rise in the number of endometrial cancer 
patients, as well as a decrease in the age of onset. The majority of these cases 
are associated with chronic anovulation (5, 6). Anovulation is found to be 
associated with elevated estrogen level in the blood, and this increase woman 
risks to develop endometrial cancer. Studies showed that women with Poly 
Cystic Ovary Syndrome (PCOS) and women with estrogen-secreting ovarian 
tumors are more prone to have endometrial cancer especially in their 
reproductive life (59, 60). A study performed on young women showed, that 
almost third the cases with endometrial cancer have PCOS (5, 61). It was also 
shown that woman with irregular menstrual cycles were at a higher risk for 
endometrial cancer than woman with normal cycles. Some other studies have 
shown that PCOS, and insulin resistance, which are both components of 
metabolic syndrome, may play a pivotal role in the pathogenesis of endometrial 
cancer, perhaps through disruption of hormonal processes (62). On the other 
hand, ovulation-stimulating drugs such as clomiphene widely used by infertile 
women, has recently been reported to be risk factor for uterine cancer by 
increasing estradiol levels (63).  
 
2.3.8. Nulliparity   
Nulliparous women are at increased risk for endometrial cancer compared to 
parous women, and high parity was found to be negatively associated with 
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endometrial cancer (64, 65). During pregnancy, the hormonal balance shifts 
toward more progesterone, which plays as a protective factor against endometrial 
cancer. Therefore, multiple pregnancies were observed to reduce endometrial 
cancer risk compared to higher risk of endometrial cancer of multi-parous (64). 
Maternal age at first birth and parity seems to interact (65). Parity might be a sign 
of different levels of oestrogens because oestrogen is some how higher in the 
first than in the second pregnancy (66). Increasing maternal age at first birth is 
associated with an increasing relative risk of endometrial cancer (65). Nulliparity 
is not only associated with increased endometrial cancer but also with decreased 
survival rate among patients with endometrial cancer.  Studies found that 55% of 
endometrial cancer patients were nulliparous, with an approximate incidence of 
71% in women aged 40 years or younger (47). 
 
2.3.9. Age at first and last live birth 
Age when mother delivered her baby is important, as it found to be significantly 
related with the increase risk of endometrial cancer (47, 49, 67, 68, 69). Age at 
first pregnancy does not appear to have any significant relationship with 
endometrial cancer in most studies. The risk of endometrial cancer decreased 
when women delay the birth of last child later on in comparison with women who 
complete their reproductive life earlier (69, 70).  
 
2.3.10. Numbers of miscarriages  
Although early ending of pregnancy as well as miscarriage have shown to be 
correlated positively with increasing risk of breast cancer, epidemiological studies 
either reported no relationship (47, 71, 72), or considered early end of pregnancy 
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as protective factor (64, 73,74,75) for endometrial cancer. Significant relationship 
between endometrial cancer and number miscarriages can be existed in 
univariate analysis, but after adjusting for other factor this relationship may 
disappear (76).  
 
2.3.11. Estrogen therapy (ET) 
Estrogen Therapy (ET) is the use of estrogen to offset the symptoms of 
menopause. Estrogen is used to be prescribed alone to treat symptoms of 
menopause such as hot flushes (77, 78). Epidemiological and clinical studies 
have shown that endometrial cancer as a disease is connected with high level of 
exposure to estrogen, and the use of estrogen alone increases the risk of 
endometrial cancer by five times, as it causes delay in the  age of menopause. 
This finding has resulted in a huge reduction in the use of unopposed estrogen 
by postmenopausal women without hysterectomy since 1980 (79). However, a 
diverse combination of estrogen plus progestin regimens soon became available 
for women without hysterectomy (80). Controversy among researchers regarding 
the relation between the sequential estrogen plus progestin regimens and 
endometrial cancer are continuous. Many studies reported a significant increase 
in endometrial cancer risk with the use of estrogen plus progestin regimens, 
although not as much as unopposed estrogen does (81-84). In a study performed 
in the UK and based on a huge number of postmenopausal women without 
hysterectomy, no association of endometrial cancer with sequential estrogen plus 
progestin use were reported (85).  Studies have reported a positive relation 
between combined estrogen and progestin regimens and the risk of developing 
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breast cancer (81, 83). It has been suggested that if woman chose to use the 
new therapy, it is better to use it at the lowest possible dose and for the shortest 
possible time, and to have a yearly check up (81).  
 
Most of the evidence regarding estrogens and cancer risk deals with exogenous 
estrogens and suggests an increased risk of (fatal) breast and endometrial 
cancer among hormone replacement therapy users (86, 87). However, several 
studies indirectly provide support for an association between exposure to 
endogenous estrogens and an increased risk of breast cancer, endometrial 
cancer, and ovarian cancer (88, 89).                                    
 
2.3.12. High fat diet 
Environmental factors, including those related to diet, are believed to contribute 
significantly to the etiology of many forms of cancer (90). Studies have shown a 
positive relation between endometrial cancer and high-fat diet (91, 92, 93). This 
can be explained in two ways. Firstly, a high level of fat in daily food can lead to 
the development of obesity that, in turn is considered to be a risk factor for 
endometrial cancer. The second explanation is that a fatty diet affects estrogen 
metabolism, which increases the risk of endometrial cancer (94, 95). 
 
2.3.13. Obesity 
The relation between obesity and endometrial cancer risk has been the subject of 
many studies. Numerous of these investigations have shown that increasing body 
weight is recognized as determinant of endometrial cancer especially in 
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developed countries (96). Obese women have a 3-fold higher risk compared with 
under weight or normal weight women (49, 97). Although most of a woman's 
estrogen is produced by her ovaries, fat tissue in obese women can change 
some other hormones into estrogens. Having more fat tissue can increase a 
woman's estrogen levels and therefore increase her endometrial cancer risk. To 
the contrary, the risk of endometrial cancer in obese premenopausal women is 
due to progesterone deficiency rather than an excess of oestrogen (98). In 
comparison with women who maintain a healthy weight, endometrial cancer is 
twice as common in overweight women, and more than three times as common 
in obese women. The strong interaction between BMI and endometrial cancer, 
supports the hypothesis that, hyperinsulinaemia is an etiologic factor for 
endometrial cancer (35). Insulin may be an important factor in explaining the 
strong relations between the risk of endometrial cancer and adiposity (99). 
Furthermore, obesity may affect endometrial cancer through increase the risk of 
diabetes and hypertension, which both shown to increase the risk of endometrial 
cancer risk (96, 97). 
 
2.3.14. Diabetes 
 
Studies have found a positive correlation between diabetes and endometrial 
cancer; however it is unclear whether this relationship is due to the diabetes 
itself, or due to complications with weight (47, 100, 101). As most people with 
type 2 diabetes are overweight or obese, the chances of having endometrial 
cancer in woman with type 2 diabetes are two to four times higher than non-
diabetic woman (47, 100). However, some studies found that endometrial cancer 
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risk is higher in women who are overweight and diabetic than in women who are 
overweight but not diabetic. Some studies have shown that women with type 1 
diabetes tend to have high risk of endometrial cancer despite not being obese, 
while other studies show no relation with type 1 diabetes (47, 101).  
 
2.3.15. HIV/AIDS 
Infection by human retroviruses, particularly HIV-1/2, is a major public health 
problem worldwide, especially in Africa. The previous, beside new HIV-AIDS, 
defining cancers (102, 103, 104), have put the epidemiologists under new 
challenges, first to find the exact  kind of cancers that related to HIV, and second 
to find the mechanism/s the connected these diseases with each other. So far, 
no study reported a relationship between endometrial cancer and HIV. 
 
2.3.16. Hypertension 
Hypertension is a disease usually associated with heavy weight, and older age. 
Patients with endometrial cancer may suffer from hypertension, because either 
they are aged, or obese or both (47, 105). Despite the previous facts, at least 
one study had suggested link between hypertension and endometrial cancer 
(106).   
 
2.3.17. Tamoxifen 
Women who used Tamoxifen to treat metastatic breast cancer or to prevent 
recurrence of breast cancer are under risk of developing endometrial cancer 
(107, 108). Tamoxifen acts like estrogen in the uterus causing the uterine lining 
to grow, and as the duration of treatment increases the thickness of the uterine 
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lining increases (109). The risk of endometrial cancer and the severity of the 
diseases which usually associated with poorer survival rate found to be increased 
with duration of use Tamoxifen (108). It has been estimated that 20 of each 1000 
women used Tamoxifen for at least 10 years will develop endometrial cancer 
later on (110, 111).  
 
2.3.18. Prior pelvic radiation therapy 
Endometrial cancer risk may increase after the surrounding areas have been 
exposed to radiation. Treating other sorts of cancers with radiation can cause 
damage to the DNA of cells, which may increase the risk of a second type of 
cancer such as endometrial cancer (112).  
 
2.4. Study question 
 
What are the risk factors associated with endometrial cancer in black South 
African women. 
2.5. The Aim/Aims of this study 
2.5.1 General 
To investigate the relationship between certain risk factors and endometrial 
cancer in Black South African women who were admitted at Johannesburg 
tertiary hospitals.                     
2.5.2 Specific  
To determine the association between geographical, socioeconomic factors, 
reproductive factors, diseases like HIV-AIDS, diabetes, hypertension, and 
endometrial cancer in Black South African women at Johannesburg tertiary 
hospitals.
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3.1 Study Design 
 
This an age matched case control study is based on data collected from 1995 to 
2004 by the Cancer Epidemiology Research Group, which has interviewed black 
South African women with newly diagnosed cancer, at Johannesburg’s tertiary 
hospitals. The present study examines the role of a variety of possible risk 
factors as well as the use of exogenous estrogens in the epidemiology of 
endometrial cancer. 
 
3.2. Study population 
The study population comprised 592 female Black South Africans admitted to 
three hospitals located in the city of Johannesburg; Chris Hani Baragwaneth 
Hospital, Hillbrow Hospital, and Johannesburg General Hospital. All admitted 
cases agreed to participate in the study (100% participation rate). Participation 
rate in the control group was 90%. Control group participants were cancer 
patients as well so that their attendance to the interview depended on their ability 
to speak (i.e. some cancer like oesophageal cancer, mouth, cancer, and tongue 
cancer was not able to speak). 
 
One hundred and forty eight black women aged 27-90 years with endometrial 
cancer, diagnosed and histological confirmed during the period 1995-2004 
constitute the case population. Every endometrial cancer case was matched with 
3 control subjects of similar age (either exactly the same age or ±1 year), as this 
ratio (1case: 3 controls) ensures the required statistical power to answer the 
study objectives (table 1 in the appendix). Control subjects comprised women 
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admitted to the main hospitals in the city of Johannesburg with other types of 
cancers unrelated to gynaecological cancers, such as cancers of the colon, 
brain, kidney, and lung. The Cancer Epidemiology Research Group previously 
established using other cancers as controls to be a valid method in papers 
published in international journals, arising from this case control study (113).  
 
3.3. Diagnosis and confirmation of the cases 
Women usually visit the clinic when they have unusual vaginal bleeding, or any 
other symptoms that suggest a possibility of endometrial cancer or any female 
cancer. In the current study, confirmation of the cases was done in two different 
ways either by endometrial biopsy, which is the usual way that a pathologist 
confirms cancer or by assessing the thickness of the endometrium by using 
transvaginal ultrasound probe. Indeed this technique can help differentiate 
benign from malignant causes of bleeding, because only around 8–10% of 
women who experience postmenopausal bleeding have endometrial cancer 
(114). According to this technique a woman does not need to undergo a biopsy, 
when the endometrial tissue thickness measures less than 5 mm, which has 
negative predictive value of 99%. However, in premenopausal women, it is more 
difficult to find out if the thickening is due to cancer as they normally have a 
thicker endometrial stripe. Therefore, we here suggest to use another newly type 
of ultrasound known as a sonohysterography involving placing fluid in the uterus 
to get a better view of the endometrial stripe in future studies.  In order to avoid 
any mistake in diagnosis in future studies, it is however important to establish a 
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'one-step' rapid access clinic, which combines clinical evaluation, ultrasound, and 
if necessary, an endometrial biopsy (114).  
 
3.4. Premenopausal and Postmenopausal women  
Menopause means the permanent physiological or natural, cessation of 
menstrual cycles. In other words, menopause means the natural and permanent 
stopping of the monthly female reproductive cycles, and in humans this is usually 
indicated by a permanent absence of monthly periods or menstruation. 
Technically it refers to the final period, but because it is a gradual process no 
sudden events, a period of time equal 24 months after the last period, had been 
taken into account when we considered a woman as postmenopausal. Any 
women reporting a period within 3 months period, was considered as 
premenopausal, even if the period was absent the last 21 months before 
 
3.5. Inclusion and exclusion criteria 
Study participation was restricted to women admitted to the previously mentioned 
hospitals located in Johannesburg. Only newly occurring cases (incident) were 
included. Generally, the definition of case assumes that, for any disease people 
are divided into two discrete classes the affected (diseased) and non- affected 
(not having the exact disease). In the current study cases were diagnosed by 
biopsy/ultrasound, so that we are relatively certain that endometrial cancer cases 
are cases. According to diagnosis criteria, cases were Black South African 
women clinically diagnosed and confirmed recently with endometrial cancer, at 
previously mentioned main public hospitals. 
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Cases were premenopausal women and postmenopausal women, have been 
diagnosed with endometrial cancer not before six months (as average time), 
when they were interviewed in this study.  Women in the control group consisted 
of those with cancers not associated with reproductive or hormonal factors, i.e. 
cancers of the breast or the female reproductive system. We have excluded from 
the control group any women who previously had a hysterectomy. Women who 
were admitted to a different hospital were excluded from both the case and 
control groups. Control subjects without an intact uterus were replaced with 
another eligible subject. 
 
 3.6. Data collection 
A structured interview, on average 60 minutes in length, was administered to 
obtain information about hypothesized risk factors, including demography, 
pregnancy history, menstrual history, contraceptive use, diet, alcohol intake, 
place of cooking, smoking and residence (see index).  Nurses trained in 
interviewing, questioned cases and controls of this study at Chris Hani 
Baragwaneth, Hillbrow, and Johannesburg Hospitals using a structured two page 
questionnaire. As mentioned before, women were considered to be 
postmenopausal if they said they had not had a period within two years of the 
date of the interview, whereas women who had a menstrual period within three 
months of the time of interview were considered to be premenopausal. 
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All subjects were questioned to determine hysterectomy status, while HIV status 
was ascertained though laboratory test. Serum specimens were stored at -20 to -
30º prior to being batched for HIV testing. HIV testing was done using the Abbott 
Axysm HIV1/2 gO Microparticle Enzyme Immunoassay. Thereafter the 
Vironostika (HIV Uni-Form II plus O) microELISA has been used (102). Less than 
1% of the patients refused testing. 
The interviews for both cases and control groups were conducted in the preferred 
language of the patient (usually Sesotho or Zulu) following written or verbal (if 
illiterate) consent to participate. The questionnaires were anonymous and 
included questions on smoking, frequency of alcohol consumption, birthplace, 
residence, education, reproductive, contraceptive and lifetime sexual history. 
Information on exposure to established and proposed risk factors and on other 
relevant variables has been obtained by means of a structured questionnaire 
administered by trained interviewers.  
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3.7. Data analysis 
 
3.7.1. Data extraction and cleaning 
Data handling, cleaning and analysis was done using Stata 9 (STATA). Data 
cleaning was started by listing all variables then checking if any of the figures 
related to these variables were missing. 
 
3.7.2. Descriptive analysis 
To determine at which age-categories black women get diagnosed most often 
with endometrial cancer, five year age intervals were chosen to see the 
distribution of cases, and also to compare the distribution of the cases and the 
controls. Three tables have been constructed to display the frequency of the 
variables of interest. Before comparing cases and controls according to their age 
group, a full description of each control regarding the kind of cancer that the 
patient has, number of patients for each type, age at disease diagnosis, have 
been given. To compare characteristics of cases and controls, we used Chi- 
square test for categorical variables, while for continuous variables we used t-
test, ANOVA, and Mann Whitney.   
 
3.7.3. Analytic analysis 
Conditional logistic regression analysis was used to investigate the association 
between each risk factor and endometrial cancer in univariate models. Odds 
ratios and corresponding 95% confidence intervals were estimated and p-values 
were calculated to test the significance at 5% significance level. Confounding 
factors were taken into account in multiple logistic regression and models 
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including diabetes and HIV status. The variables that demonstrated a significant 
association with endometrial cancer in univariate models were entered into 
multiple logistic regression models. All variables significantly related to 
endometrial cancer risk were initially included in a full multiple logistic elimination.  
Factors that were significant at 5% were returned in the final model. We then 
systematically built a multiple logistic regression model by removing the factors 
with the largest Wald-stattistic p-value, and compared the subsequent log 
likelihood ratio chi-squares. If the removal of the factor did not significantly 
change the log-likelihood, then the factor was dropped. The process was 
repeated until we could not drop factors any further. Interactions between 
variables were assessed by inclusion of interaction terms in the logistic 
regression models. In order to detect any changes in the significance of the 
variables we stratified by HIV, Diabetes, and hypertension.  
 
 
3.8. Ethical approval 
This study has been approved by the University of Witwatersrand human ethic 
committee (ethics clearance number: M981119). A letter of permission from the 
Head of the Cancer Epidemiology Research Group and a copy of the ethical 
approval letter have been attached in the appendix of this report. The participants 
gave signed informed consent. 
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4.1. Results 
 
 
This study was designed to explore risk factors for endometrial cancer in Black 
South African women in the city of Johannesburg. In this chapter, results from 
the data analysis using Chi-square analysis comparing demographic, 
reproductive and lifestyle factor for cases of endometrial cancer and controls are 
presented. All variables significantly related to endometrial cancer risk were 
initially included in a full multiple logistic elimination.  
 
After adjusting for other variables , the significant variables that I got in my 
multivariate analysis were; number of miscarriages, age at menarche, age of 
youngest child which represented the of mother at last birth, while smoking was 
significantly protective against endometrial cancer. Stratification by HIV, 
Diabetes, and hypertension did not show any changes in the significance of the 
variables. I have also looked at the interaction between variables and was found 
none. 
 
4.2. Descriptive statistics 
Data was analysed using Stata 9 software comparing characteristics of cases 
with controls.  Chi square analysis results have been divided in to three tables, 
according to the relation among the variables in each table. Tables; 4-1, 4-2, 4-3 
compare demographic, reproductive and lifestyle factors for cases of endometrial 
cancer and controls. Table 4-4 displays univariate and multivariate analysis 
results. While, tables, 3, 4, and 5 in the appendix compare demographic, 
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reproductive and lifestyle factors for cases of endometrial cancer and controls as 
percentages.  
 
4.3. Description of data set 
 
The study population comprised 592 patients. The youngest participant was 27 
years old, while the oldest was 90 years old, and the average age was 60.3, with 
an S.D. of 13.61. All participants were black patients admitted to previously 
mentioned hospitals in the city of Johannesburg, South Africa. The relationship 
between age and cancer diagnosis was studied by dividing the participants in this 
study into 13 groups according to their age, starting from age group 25-29, to age 
group 85-90. The majority of the participants fell within the 55-75 age group 
(table 1 in the appendix). These patients represented 57.4% of the total study 
participants.   
 
One hundred and forty eight patients with endometrial cancer were recruited as 
cases and 444 patients with different types of cancer (excluding gynaecological 
cancer) were recruited as controls (table 2 in the appendix). As seen in table 4-2, 
more cases had miscarriages than did controls. More controls than cases 
reported that their oldest child was less than 56 years old, while more cases than 
controls reported that their child was over 56 when they were interviewed. 
Similarly, more controls reported that their youngest child was less than 43, 
whilst more cases reported that their youngest child was over the age of 43. A 
higher percentage of the cases reported that their monthly cycle had started 
when their ages were between 11 and 14 years when compared with the control 
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group. Most of the controls reported that their monthly cycle had started after the 
age of 15 years.  
Although similar percentages of cases and controls reported that their period 
ended before 39 years old, the percentage of cases who reported that their 
period had ended after the age of 50 years was greater than the controls.  
Out of the total number of cases and controls, cases were less likely to report 
that they smoked, at the time of the interview when compared to the controls. 
Finally, more cases than controls reported that they were HIV positive at the time 
of the interview. Tables 4-1, 4-2, and 4-3 provide a detailed description of the 
cases and controls of the current study.   
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9% HIV Possitive
12% Missing Data
79% HIV Negative
 
Figure 4-1 HIV status among Black South African women (cases and controls). 
 
    
 
 
 
Figure 4-2 Relationship between age and endometrial cancer among Black South 
African women (cases). 
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4.4. Univariate and multivariate analysis of factors associated with 
endometrial cancer 
4.4.1. Socioeconomic Factors 
4.4.1.1. Educational level 
 
University education seemed to be associated with increased odds of developing 
endometrial cancer in this study whilst other levels of education, lower than the 
university level, tended to be protective. These associations were however 
statistically insignificant (Table 4-4). 
 
4.4.1.2. Place of former residence 
                              
Compared to women who had resided in Soweto for a long period, long 
residence in Gauteng, Northern Cape, Mpumalanga and North West Provinces 
were significantly associated with increased risk for endometrial cancer (Table 4-
4). However, the highest risk was associated with residence in the Mpumalanga 
(OR; 4.03, 95% CI: 1.64-9.89) and North West Province (OR; 5.03, 95% CI: 2.11-
12.01).  
 
4.4.2. Lifestyle factors      
4.4.2.1. Snuff use 
Compared to non-snuffer, current snuffer were almost twice as likely to have 
endometrial cancer (OR; 1.91, 95% CI: 1.17-3.13), while snuff use found to have 
a protective effect in former snuffer (OR; 0.66, 95% CI: 0.34 -1.28). 
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4.4.2.2. Smoking                                                                                                 
Compared to non-smokers, current smokers (OR; 0.34, 95%CI: 0.16-0.75) and 
former smokers (OR; 0.39, 95% CI: 0.20-0.77) in this study were less likely to 
have endometrial cancer. Moreover, the protective effect of current or past 
smoking remained significant after adjusting for confounders in the multivariate 
model (Table 4-4). Hence, women in the former smokers’ category were about 
0.64 times less likely to have endometrial cancer whilst those in the current 
smokers’ category were 0.73 times less likely to have endometrial cancer.  
 
4.4.2.3. Wine consumption 
Women who reported drinking wine more than once a week were more likely to 
have endometrial cancer by almost 12 fold compared to those who did not drink 
wine. On the other hand, those who drank wine less than once a week were less 
likely to have endometrial cancer compared to those who reported that they 
never drink wine, despite the fact that this relation was not significant (OR; 
0.50,95% CI :0.08-3.25). No such relationship was found in multivariate analysis. 
 
4.4.3. Reproductive Factors 
4.4.3.1. Age at menarche 
Women who had their first menstruation between ages 15-18 years (R; 0.49, 
95% CI: 0.33-0.74) were less likely to have endometrial cancer compared to 
those who had their first menstruation between ages 11-14 years.  These results 
were consistent with Chi-square analysis (table 4-2), univariate analysis and 
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multivariate analysis (table 4-4). Hence for every one year delay in the age of 
menarche, women in the 15-18 years category were at reduced risk of 
endometrial cancer by about 0.51.  
 
4.4.3.2. Age at menopause 
Women who had their menopause between the ages 51-60 years (OR; 2.66, 
95% CI: 0.96-7.33) were more likely to have endometrial cancer compared to 
those who had ended their menstruation between the ages (30-39 years). 
 
4.4.3.3. Number of miscarriages  
Compared to women with no history of miscarriage, those with a history of three 
or more miscarriages were almost four times as likely to have endometrial cancer 
(OR; 3.98, 95% CI:2.06-7.70). Though the effect of multiple miscarriages on 
endometrial cancer attenuated after adjusting for potential confounders in the 
multivariate model, it remained significant (OR; 3.17, 95% CI: 1.52-6.58).    
 
4.4.3.4. Menstrual period (The duration from menarche to menopause) 
Menstrual period (reproductive span) was generated by subtracting the age of 
menarche from the age at menopause. In univariate analysis, the effect of 
menstrual period on endometrial cancer was statistically insignificant for women 
who had menstruated for a period of 25-34 years (OR; 1.19, 95% CI: 0.50-2.85), 
and women who had menstruated for a period of 35-46 years (OR; 2.41, 95% CI: 
0.98-5.91). 
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4.4.3.5. The age of youngest child or age at last live birth 
Age of the youngest child refers to the women ages’ at the last successful 
delivery (age at last live birth), and can also refer to their ages at the last 
successful pregnancy. Compared to women who had children aged between 1-
14 years, those who had older children had more chance to develop endometrial 
cancer. In another word women who had their last birth at earlier age had 
increased odds of developing endometrial cancer, the risk increased with 
increasing age of the youngest child (table 4-4).The effect of age at time of last 
live birth remained significant in the multivariate model for women in the 29-42 
years category (OR; 3.67, 95% CI: 1.37-12.69) and 43-65 years category (OR; 
8.78, 95% CI: 2.73-40.87). 
 
4.4.4. Other risk factors and endometrial cancer 
Further risk factors examined were diabetes, hypertension and HIV status. Due 
to considerable numbers of missing data especially for diabetes and HIV these 
variables were investigated separately in the multivariate model to assess their 
association with endometrial cancer in the subpopulation whom on diabetes, 
hypertension and HIV status was available. 
 
4.4.4.1. Diabetes  
In univariate analysis, the relationship between diabetes and endometrial risk 
was significant (OR; 2.70, 95% CI: 1.19-6.11), while this relation was non-
significant in multivariate analysis (OR= 2.23, 95% CI: 0.93- 5.34).  
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4.4.5.2. HIV 
There was an inverse significant relationship between HIV and endometrial risk 
in the univariate analysis (OR= 0.42, 95% CI: 0.18-0.97). No significant 
relationship found in the multivariate analysis (OR= 0.43, 95%: CI: 0.17- 1.10). 
 
4.4.5.3. Hypertension 
The relation between hypertension and endometrial risk was significant in the 
univariate analysis (OR=2.94, 95% CI: 1.67- 5.17). A significant relationship has 
been detected between hypertension and endometrial cancer risk in multivariate 
(OR= 3.16, 95% CI: 1.68- 5.92).  
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Table 4-1 Comparison in demographical factors between cases and controls among 
Black South African women, at Johannesburg tertiary hospitals between 1995 and 2004 
 
Variables  Controls  No. Cases  No. P-value 
Total Number 
Age (mean) 
Highest age (years) 
Youngest age (years) 
Standard deviation 
444 
60.30 
90 
27 
13.63 
 148 
60.30 
90 
27 
13.63 
  
Education level 
No schooling  
Grade 1 to grade 4 
Grade 5 to grade 7 
Grade 8 to grade 10 
Grade 11  to grade 12 
University level 
 Missing data 
 
25.7% 
9.2%   
20.5% 
26.4% 
16.0%   
1.6% 
 0.7% 
444 
114 
41 
91 
117 
71 
7 
3 
 
 31.1% 
 9.5% 
18.2% 
 20.3% 
18.2% 
 2.7%   
----------  
148 
46 
14 
27 
30 
27 
4 
P= 0.514 
 
Pension status 
Yes 
No 
Missing data 
 
23.0% 
16.2% 
60.81% 
444 
102 
72 
270 
 
  22.3%  
  25.0% 
  52.7%  
148 
33 
37 
78 
P= 0.052 
Place of residence (Urban/Rural) 
Urban areas 
Rural  areas 
Missing data 
 
82.9% 
16.0% 
1.1% 
444 
368 
71 
5 
 
 79.7% 
 19.6% 
  0.7% 
148 
118 
29 
1 
P= 0.546 
Place of birth 
Soweto 
Johannesburg 
Gauteng 
North Province  
Kwazulu Natal 
Free State  
North West  
Mpumalanga   
                               
 
 
Missing data 
 
 7.5% 
 9.1% 
 22.9% 
 13.1%   
 16.7%   
 13.4%   
  9.7%    
  7.7% 
 
 
 
 0.45  
444 
33 
40 
101 
58 
74 
59 
43 
34 
 
 
 
2 
 
 4.7% 
 5.4% 
32.4% 
15.5% 
13.5%  
15.5% 
 6.8%         
6.1% 
 
 
 
------ 
148 
7 
8 
48 
23 
20 
23 
10 
9 
 
 
 
---- 
P= 0.181 
Place of current residence 
Soweto 
Johannesburg 
Gauteng 
Kwazulu Natal 
Northern province  
Free State  
North West  
 
Missing data 
 
 38.1% 
 13.5%   
 28.4%  
 5.0%  
  6.1%   
  2.9% 
  5.9% 
 
   0.23%  
 
444 
169 
60 
126 
22 
27 
13 
26 
 
1  
 
27.0% 
10.8%  
36.5% 
6.8% 
10.8% 
3.4% 
4.7% 
 
0.0000 
148 
40 
16 
54 
10 
16 
5 
7 
 
----- 
P= 0.081 
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Table 4-2 Comparison in reproductive factors between cases and controls among Black 
South African women, at Johannesburg tertiary hospitals between 1995 and 2004 
 
Variables Controls% NO Cases% NO P-value 
Age at Menarche 
Age 11-14 years 
Age 15-18 years 
Age 19-22 years 
Missing data 
 
28.6%     
61.3% 
 6.1%  
 4.1% 
444 
127  
272 
27 
18 
 
45.3% 
47.3% 
4.7% 
 2.7% 
148 
67 
70 
7 
4 
P= 0.003 
Age at Menopause 
Age 30-39 years 
Age 40-45 years 
Age 46-50 years 
Age 51-60 years 
Missing data 
 
5.0% 
15.3% 
36.7% 
19.1%   
23.9% 
444 
22 
68 
163 
85 
106   
 
 6.8% 
 12.2% 
 35.8% 
 33.1% 
 12.2% 
148 
10 
18 
53 
49 
18 
P= 0.001 
Ever pregnant 
Yes 
No 
Missing data 
 
95.0% 
5.0% 
---------- 
444 
422 
22 
----- 
 
92.6% 
6.8% 
0.7% 
148 
137 
10 
1  
P= 0.154 
Full term pregnancies  
Once 
Twice 
Three times 
Four times 
Five times or more 
Missing data 
 
 8.1% 
13.3% 
11.7% 
15.5% 
46.2% 
5.2 %  
444 
36 
59 
52 
69 
205 
 23 
 
9.5% 
17.6% 
14.2% 
10.1% 
39.2% 
 9.5% 
148 
14 
26 
21 
15 
58 
14 
P= 0.111 
Age of the Child   
1.  Oldest child 
Age 2-19  years 
Age 20-37 years 
Age 38-55 years 
Age 56-76 years 
Missing data 
 
2. Youngest child 
Age 1-14  years 
Age 15-28 years 
Age 29-42 years 
Age 43-65 years 
Missing data 
 
 
8.8% 
27.3% 
47.5% 
6.5% 
9.9%  
 
 
15.3% 
26.1% 
33.1%   
5.9% 
19.6 %  
 
444 
39   
121 
211   
29 
44  
 
444 
  68  
 116 
147 
  26   
  87 
 
 
4.7% 
19.6% 
44.6%  
7.4% 
23.7% 
 
 
4.7% 
18.2%   
28.4% 
9.5% 
39.2% 
 
148  
  7 
29 
66 
11 
35 
 
148 
7 
27 
42 
14 
58 
 
P= 0.000 
 
 
 
 
 
 
P= 0.000 
Miscarriages 
Never had  miscarriage  
One miscarriage 
Two miscarriages 
Three or more miscarriages 
Missing data  
 
36.3% 
19.1%   
8.3% 
5.6% 
30.6%  
444 
161 
85   
37  
25  
136   
 
25.7% 
22.3% 
11.5%  
16.2% 
24.3% 
148 
38 
33 
17 
24 
36 
P= 0.000 
Oral contraceptives 
Yes 
No 
Missing data 
Injectable contraceptives 
Yes 
No 
Missing data 
 
13.7% 
85.8% 
 0.5% 
 
12.8% 
 86.0% 
1.1%  
444 
61 
381 
2 
444 
57   
382 
5 
 
 14.2% 
 85.8% 
-------- 
 
 9.5% 
 90.5% 
--------- 
148 
21 
127 
----- 
148 
 14 
134 
----- 
P= 0.711 
 
 
 
P= 0.225 
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Table 4-3 Comparison in lifestyle factors between cases and controls among Black 
South African women, at Johannesburg tertiary hospitals between 1995 and 2004 
Variables Controls% No Cases% No P-value 
Snuff use 
Current  
Former  
Never 
Missing data 
 
13.3%   
13.1% 
73.4% 
0.2% 
444 
59 
58 
326 
1 
 
23.0% 
8.1% 
68.2% 
0.7% 
148 
34 
12  
101 
1 
P= 0.018 
Snuffing frequency 
1-4 times daily 
5-9 times daily 
10-20 times daily 
Missing data 
 
12.39% 
7.88% 
5.41% 
74.32% 
444 
55 
35 
24 
330 
 
18.2%    
6.8% 
6.1% 
68.9% 
148 
27   
10  
 9 
102 
P=  0.325 
Smoking status 
Current 
Former  
Never  
Missing data 
 
12.4% 
15.5% 
71.6% 
 0.5% 
444 
55 
69 
318   
2 
 
5.4% 
7.4 %  
87.2%  
--------- 
148 
8 
11 
129 
------ 
P= 0.002 
Age when start smoking  
Age 10-16 
Age 17-24 
Age 25-50 
Missing data 
 
7.0 %  
13.7% 
 5.6% 
73.7%   
444 
31 
61 
25 
327   
 
2.70% 
5.41% 
2.70% 
89.19% 
148 
  4 
  8 
  4 
132 
P= 0.001 
Age of stop smoking 
Age  15-30 
Age  31-46 
Age  47-62 
Age  63-76 
Missing data 
 
 1.8% 
 2.5% 
 5.2%   
 2.3% 
 88.3%   
444 
 8 
 11 
 23   
 10   
 392   
 
2.0% 
2.7% 
0.7%  
1.4% 
 93.2% 
148 
3 
4 
1 
2 
138 
P= 0.174 
Wine consumption 
Most days 
More than once a week 
Less than once a week 
Never  
Missing data 
 
2.7%   
0.2% 
2.7% 
40.3%   
54.1% 
444 
12   
1 
12   
179 
240   
 
 2.7% 
 2.7% 
 1.4%  
 49.3% 
 43.9% 
148 
4 
4 
2 
73 
65 
P= 0.010 
Maize Beer  consumption 
Most days 
More than once a week 
Less than once a week 
Never  
Missing data 
 
 2.9%   
 3.8%   
 6.5% 
 32.4%   
 54.3%   
444 
13 
17 
29 
144 
241 
 
 3.4% 
 3.4% 
 12.8% 
 37.2% 
 43.2% 
148 
5 
5 
19 
55 
64 
P= 0.063 
Diabetes 
Yes 
No 
Missing data 
 
 3.8% 
 50.9% 
 45.3% 
444 
17 
226 
201 
 
 7.4% 
 35.8% 
 56.8% 
148 
11 
53 
84 
P= 0.003 
Hypertension 
Yes 
No  
During pregnancy 
Missing data 
 
 23.0% 
 36.3% 
 0.2%   
 40.5%   
444 
102 
161 
    1   
180 
 
 30.4% 
16.2% 
 00.00 
 53.4% 
148 
45 
24 
00 
79 
P= 0.000 
HIV 
Yes 
No 
Missing  data 
 
10.6% 
78.8% 
10.6% 
444 
47 
350 
 47 
 
4.7% 
77.7% 
17.6% 
148 
7 
115 
 26 
P= 0.014 
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Table 4-4 Association between demographical, reproductive, life style factors 
and endometrial cancer among Black South African women, at Johannesburg tertiary 
hospitals between 1995 and 2004  (Univariate analysis) 
           Univariate Analysis 
Variables  Odds Ratio p-value 95% CI* 
Education 
No schooling 
School (Grade 2/4) 
School (Grade 5/7) 
School (Grade 8/10) 
School (Grade 11/12) 
University 
 
1 
0.55 
0.73 
0.29 
0.83 
1.33 
 
 
0.472 
0.651 
0.085 
0.827 
0.665 
 
 
0.11 -   2.80 
0.19 -   2.81 
0.07 -   1.19 
0.15 -   4.63 
0.36 -   4.88 
Miscarriages   
No miscarriage 
One miscarriage 
Two miscarriage 
Three or more miscarriages 
 
1 
1.63 
1.90 
3.98 
 
 
0.075 
0.061 
0.000 
 
 
0.95 -  2.80 
0.97 -  3.72 
2.06 -  7.70 
Place of former residence  
 Soweto 
 Johannesburg 
 Gauteng  
 N. Province  
 Mpumalanga  
  N. West Province 
 
1 
1.88 
3.33 
2.75 
4.03 
5.03 
 
 
0.273 
0.018 
0.024 
0.002 
0.000 
 
 
0.61 - 5.78 
1.23 - 9.04 
1.14 - 6.64 
1.64 - 9.89 
2.11 -12.01 
Place of current residence 
Soweto 
Gauteng  
N Province  
KwaZulu Natal 
 
1 
1.92 
2.52 
4.90 
 
 
0.008 
0.010 
0.002 
 
 
1.18 - 3.12 
1.24 -5.11 
1.76 -13.68 
Use of Snuff  
Never snuff 
Former  snuffer 
Current snuffer  
 
1 
0.66 
1.91 
 
 
0.217 
0.010 
 
 
0.34 -1.28 
1.17 -3.13 
Wine consumption  
Non-drinkers 
Drinking wine more than once a week 
Drinking wine less than once a week 
 
1 
11.72 
0.50 
 
 
0.049 
0.468 
 
 
1.01 - 136.18 
0.08 - 3.25 
Ever smoke 
Never  
Former  
Current  
 
1 
0.39 
0.34 
 
 
0.006  
0.007 
 
 
0.20  -  0 .77 
0.16  -  0 .75 
Age of youngest child+ 
Age youngest child (1/14 years) 
Age youngest child (15/28 years) 
Age young child (29/42 years) 
Age youngest child (43/65 years) 
 
1 
2.64 
3.82 
8.98 
 
 
0.051 
0.009 
0.000 
 
 
1.00 -  6.98 
1.40 - 10.46 
2.68 - 30.04 
Age of oldest  child++ 
Age oldest child (2/19 years) 
Age oldest child (20/37 years) 
Age oldest child (38/55 years) 
Age oldest child (56/76 years) 
 
1 
1.41 
2.15 
3.33 
 
 
0.536 
0.190 
0.109   
 
 
0.48 - 4.15 
0.68 - 6.76 
0.76 -14.48 
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Variables  
 
Odds Ratio 
 
p-value 
 
95% CI* 
 
Diabetes 
No 
Yes 
 
 
 
1 
2.70 
 
 
 
 
0.017 
 
 
 
1.19 - 6.11 
 
Hypertension 
No 
Yes 
 
 
 
1 
2.94 
 
 
 
 
0.000 
 
 
 
1.67- 5.17 
 
HIV 
No 
Yes 
 
 
 
1 
0.42 
 
 
 
 
0.042 
 
 
 
0.18 – 0.97 
Age of menarche  
Period begins at age 11/14 years 
Period begins at age 15/18 years 
Period begins at age 19/22 years 
 
Age at Menopause  
 
Period ended at age 30/39 years                                   
Period ended at age 40-45 years 
Period ended at age 46-50 years 
Period ended at age 51-60 years 
 
1 
0.49 
0.47 
 
 
 
1 
0.91 
1.49 
2.66 
 
 
0.001 
0.098 
 
 
 
 
 
0.85 
0.42 
0.05 
 
 
0.33 - 0.74 
0.19 -1.14 
 
 
 
 
 
0.32-2.55 
0.55-4.02 
0.96-7.33 
 
Menstrual period ** 
period Length(15/24 years) 
period Length(25/34 years) 
period Length(35/46 years) 
 
 
1 
1.19 
2.41 
 
 
 
0.696 
0.055 
 
 
 
0.50 - 2.85 
0.98 - 5.91 
Menstrual status 
Period ended (menopausal woman) 
Period not ended (not menopausal)  
 
 
1 
0.23 
 
 
 
0.001 
 
 
0.10 - 0.54 
*CI: Confidence Interval; **Menstrual period is a new variable generated by subtracting the age of 
menarche from the age at menopause; + also represent the age of woman at the time of the last 
birth; ++ also represent the age of woman at the time of first birth. 
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Table 4-5 Association between demographical, reproductive, life style factors and 
endometrial cancer among Black South African women, at Johannesburg tertiary 
hospitals between 1995 and 2004 (Multivariate analysis). 
 
 
*CI: Confidence Interval; **Menstrual period is a new variable generated by subtracting the age of 
menarche from the age at menopause;  
+ also represent the age of woman at the time of the last birth 
++ also represent the age of woman at the time of first birth. 
^ All variables had been adjusted for each others 
 
         
 
 
 
 
              
Multivariate  Analysis $ 
 
Variables  
 
Odds Ratio 
 
p-values 
 
95% CI 
Miscarriages   
No miscarriage 
One miscarriage 
Two miscarriage 
Three or more miscarriages 
 
1 
1.61 
1.80 
3.17 
 
 
0.11 
0.10 
0.002 
 
 
0.90    2.89 
0.88 -  3.65 
1.52 -  6.58 
Ever smoke 
Never  
Former  
Current  
 
1 
0.34 
0.27  
 
 
0.004  
0.002  
 
 
0.17 -  0.71 
0.12 -  0.62 
Age of youngest child+ 
Age youngest child (1/14 years) 
Age youngest child (15/28 years) 
Age young child (29/42 years) 
Age youngest child (43/65 years) 
 
1 
2.48 
3.67 
8.78 
 
 
0.099  
0.012 
0.001    
 
 
0.84-  7.30 
1.37 - 12.69 
2.73 – 40.87 
 
Age of menarche  
Period begins at age 11/14 years 
Period begins at age 15/18 years 
Period begins at age 19/22 years 
 
 
1 
0.63 
0.56 
 
 
 
0.043  
0.239 
 
 
 
0.40 -  0.98 
0.22 -  1.45 
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5. Discussion  
 
The present case-control study in Black South African women evaluates risk 
factors and their relationship with endometrial cancer. To our knowledge, this is 
the first study in South Africa that aims to investigate the risk factors for 
endometrial cancer. To simplify the discussion of the results, this section has 
been divided into five major parts, and these include; the study design, the 
relationship between endometrial cancer and age, the relationship between 
endometrial cancer and social factors, the relationship between endometrial 
cancer and reproductive factors and the relationship between endometrial cancer 
and diseases like diabetes, HIV and hypertension. 
 
5.1. Discussion of the study design 
 
Studies and their results differ with regard to their quality as well as with their 
respective contribution to the evidence base. The success or failure of any type 
of epidemiological study depends on the design of an epidemiological study In 
addition, with statistical analysis, the generation of confidence intervals (CI) is 
useful because it tells the reviewer how precise the estimate is, or in the case of 
endometrial cancer treatment, how precise the percentage survival estimate 
actually is. A larger study size gives the study more solidity in terms of the results 
obtained. Another important issue is the study duration and time intervals, for 
example when reviewer compare studies it is important that they compare similar 
time periods and time intervals. Also, if a study began many years before a 
second study, it is clearly possible that the results of the two studies may vary 
simply because of changes in the standards of practice occurring during the time 
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period covered by the two studies. When two studies are conducted in two 
distinctly different time periods, even if the duration of the studies is similar, a 
difference in results obtained is possible. Materials, devices, techniques used in 
1970 to confirm diagnosis of a disease may not even be available for use a 
decade later (115). 
 
 
A case control study entails comparing the frequency of exposure in a group of 
subjects having the disease (the cases) in comparison to another group (the 
controls) who resemble them in as many relevant aspects as possible, but who 
do not have the disease or condition of interest. The measured variable, 
unknown at the onset, is exposure status to a factor that has preceded the 
occurrence of disease and possibly caused it (116). Thus, the groups in case 
control studies are indentified on the basis of the outcome. Case control studies 
are an excellent design to study rare diseases and for diseases with long latent 
and or incubation periods (117).  
 
 Before discussing the results, it is important to consider the significance of 
methodological issues. In the present case control study, we studied endometrial 
cancer, a common cancer in females. Case control design has the logistic 
benefits that it may be based entirely in health facilities and that it is relatively 
quick and easy to carry out. In the current study age matched controls were 
randomly selected from the same hospitals using other types of cancers.  
Controls were also cancerous but comprised cancers unrelated to endometrial 
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cancer. Selecting patients with cancer as controls has several advantages; first, it 
enabled us to obtain a similar quality of information. Second, it enabled us to 
recruit controls whose referral pattern was similar to those of the cases and who 
presumably came from the same study base, and were clearly identified. Third, in 
this way, we minimised recall or reporting bias and interviewer bias as much as 
possible as people with diseases may remember past events clearly or on the 
other hand may deny certain past behaviours. Lastly, choosing cancer patients 
as controls made the study easier with regard to the feasibility, and more 
economical but not perfect in term of its results (117, 118).  
 
 The disadvantages of the current design include; firstly, problems associated with 
selecting cases and controls. Theoretically, illegibility criteria for cases define the 
source population in case control studies, from which controls should be 
selected. That is if hospitalised cancer cases are biased sampling of the general 
population, controls would also be biased in the same way (119). In case control 
studies it is usually difficult to find a suitable control group. In the present study, 
we selected the control from patients admitted to same the hospitals as cases 
but with different types of cancers, although in some other studies controls have 
been selected from patients visiting cancer screening centres (119).  
 
 Secondly, it may have been possible that inclusion of other types of cancers in 
the control group might have distorted the results since the patients with other 
types of cancers may have a background similar to the patients with endometrial 
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cancer (117, 118). To minimise this problem as much as possible, patients with 
female cancers were excluded from the control group (e.g. cervical, vaginal or 
breast cancer). In the current study, however we did not compare our cases with 
healthy controls but with cases (cases vs. cases). Over estimating and/or under 
estimating of risk factor in relation to disease under study may happen. For 
example smoking is a well known risk factor for lung cancer, and using controls 
with lung cancer can result in a potential effect of smoking on endometrial cancer 
cases even when it is not. Studies like this should be repeated using different 
population as controls and by using different study designs.  
  
 Thirdly, case-control studies often cannot determine whether exposure preceded 
the outcome (temporal sequence). Although the definition of cases was strict in 
this study, it is possible however, that some of the cases might be uterus cancer 
rather then endometrial cancer, which means that not all the cases represented 
cases. Lastly, researchers consider cohort studies superior to case control 
studies. However, the cohort design is not suited to studying rare diseases like 
gynaecological cancer because the time between exposure and disease 
manifestation is very long. It is also possible that exposure patterns may change 
any time, for example the composition of oral contraceptives, may change during 
the course of the study and make the results inappropriate; or women can switch 
from oral contraceptive to injectable contraceptive; or women who smoke may 
give up on smoking and the opposite is possible. Furthermore, cohort studies are 
not ideal to cover incident cases of gynaecological cancer, as there are many 
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incidents cases of gynaecological cancer that are relatively young compared with 
cancer of other sites (120). On the other hand, case control studies can identify 
younger cases as well as at older cases. Finally, baseline data may be sparse 
because the large number of subjects does not allow for long interviews. Thus, 
case control studies are regarded as a more efficient method for investigating 
risk factors for endometrial cancer (120).   
 
  In African countries, however, feasibility to run cohort studies is controversially 
difficult due to many reasons and these include; financial difficulties, loss of 
follow up, difficulties in recruiting people, lack of expertise, time, etc.  
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5.2. The relationship between age and endometrial cancer 
 
The mean age of cases in this study (60.3 years) is well in line with international 
studies that previously considered 61 years old is the mean age for endometrial 
cancer. There were 23 cases (15.5%) under the age of 45 years, and this is 
consistent with international studies that had shown that 5-30% of the 
endometrial cancer population is found to be premenopausal (14, 121). The 
mean age of menopause in our study was 49.23 years for the cases and 48.24 
years for the controls and 48.51 years for the total population. The median age 
was 50 with a standard deviation of 5.58.  The mean age at menopause differs 
between countries, races and populations.  For example the mean age of 
menopause in the United States is 51 years, (Menarche: Mean 15.19; SD 1.89; 
Median 15, youngest 11, and oldest 21). Premenopausal women of the control 
group less than the mean age numbered 51 out of a total of 154 cases. 
 
 Not surprisingly, we have found a positive correlation between increasing age 
and the occurrence of endometrial cancer (figure 4-2), which has been widely 
reported by other studies (122). Age is also an important prognostic factor for 
survival in endometrial cancer as studies have shown that younger patients have 
a better survival than older patients (10, 16). In the present study we found two 
peaks (at ages 55-59 years, and 65-69 years), when we created age intervals of 
five years, and this was not paralleled with other studies which found only one 
peak for the cases. There are two explanations for this fluctuation, first this is 
possibly due to incomplete collecting of data, and second is the possibility that 
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women in this age group already died of other diseases. Ultimately, the total 
number of our cases in this study may be too low. Our expectation, in a bigger 
study for the same area will be one peak at the age interval 60-65.  
 
5.3. Geographical and Socioeconomic factors 
 It is widely accepted that the risk of endometrial cancer differs markedly from 
country to country, but this is mainly due to differences in socioeconomic levels, 
lifestyle, or differences among races. However, the literature has not yet shown 
significant differences within the same race living in separate areas.  
 
5.3.1. Place of birth & Place of residence 
 Like most other studies, we found no significant relationship between place 
where a woman was born or place of residence and the risk of endometrial 
cancer (35). 
 
 5.3.2. Education level  
 Although, the relationship between education and endometrial cancer is still 
controversial, it has found to have an inverse relationship with other cancers 
especially those related to smoking (36, 37). In the present study, education level 
was protective when women had a level of education (represented by school) 
between grade 8-10, however the P- value was not significant (P >0.05). The effect 
of education then started again to be less effective  for those who had education 
between grade 10 and before joining the university (those who already finished 
metric), with odd ratio close to 1 (Odd for this group = 0.912). At university level, 
the odd ratio crossed 1 (Odd= 1.33), but again the P- value was not significant (P= 
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0.665). This means that endometrial risk has increased for those who joined the 
university about 0.33 times compared to those who have no education at all. The 
difference may have been partly explained by a greater use of oestrogen 
replacement among more educated women in earlier studies or by better access to 
medical care and therefore more complete diagnosis. 
 
 On the other hand low education has been shown to be associated with high 
mortality rate in other types of cancer. Albano and colleagues have reported that 
mortality rates for lung cancer were conspicuously higher in less educated men 
than in more educated men, irrespective of race, however the differences were less 
extreme in women (38). Educated women are most probably early diagnosed, 
firstly because, they are aware of the disease, and second their economic levels 
are higher than non educated women. These reasons at the end may increase the 
survival rate significantly, not only in women with endometrial cancer but for all 
kinds of cancer (123). 
 
 5.3.3. Smoking  
The present study appears to show that smoking is a protective factor against 
endometrial cancer (P<0.05). The results of the present study are consistent with 
previously reported studies (39, 40, 41). Parazzini and colleagues have reported 
that smoking is a protective factor against endometrial cancer in postmenopausal 
women (40). Many studies have shown that the risk of endometrial cancer has 
decreased significantly in women who are currently smoker (41, 124, 125) and 
the risk continued to decrease with increased duration of smoking (39, 41,125). 
58 
 
The highest inverse relationship between smoking and endometrial risk found 
was a 40% reduction in disease risk among women currently smoking and 
among women who reported to smoke for 20 years or longer. However, the latter 
relationship was found to exist only among postmenopausal women (125). 
Newcomer and colleagues (2001) showed that among postmenopausal women, 
the risk linked with current use of postmenopausal hormones appeared to be 
greater among non-smokers than among current smokers (126). 
 
 However, in our study we do believe that part of the protective effect of smoking 
could be potentially due to the high numbers of smoking associated cancers within 
the control group (table 2 in the appendix). For example, in our study cases of 
oesophageal cancer represented 25% of the total number of participants within the 
control group. Oesophageal cancer is one of the most aggressive malignancies 
found to be significantly associated with smoking (127). Similarly other cancers in 
the control group like lung cancer (128, 129), mouth cancer and tongue cancer 
(130) that have been associated with smoking, were present in 6.98%, 2.25% and 
3.15% participants respectively in the control group. This may have influenced the 
effect size and the direction of the smoking-endometrial cancer risk association.  
   
The association between smoking and endometrial cancer risk may be attributed to 
anti- estrogenic effect of smoking (42, 43).  Estrogen can promote the development 
of endometrial cancer by initiating mutations and promoting cellular proliferation in 
endometrial glands. Androgens and progestins reduce estrogen-induced cellular 
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proliferation in endometrial glands and work against the development of 
endometrial cancer. Smokers have lower endogenous estrogen and/or higher 
androgen levels compared to nonsmokers (44, 45).  It has been shown that 
smoking reduced the age at menopause, thereby dropping the number of 
menstrual cycles that women may have in their life, which ultimately minimizes the 
effect of oestrogen in these women ultimately reducing the risk of endometrial 
cancer (46). Stockwell and Lyman have shown a protective effect of smoking 
cigarettes against endometrial cancer in women aged 50 years or older. Risks 
were significantly reduced among moderate smokers (OR = 0.6, CI= 95%), heavy 
smokers (OR = 0.4, CI=95%), and former smokers (OR = 0.6, CI=95%). However, 
this relationship was not detected among women under age 50 years (39).  
 
 The largest and most recent cohort study (43) also showed a significant decrease 
of endometrial cancer risk among current and former smoker compared to non 
smoker.  There was also an inverse association between smoking intensity and 
duration with endometrial cancer risk, although the trend was not statistically 
significant (43). To the opposite from previously reported studies, other case-
control studies showed weak to moderate inverse association between cigarette 
smoking and endometrial cancer risk (42). As a conclusion statement, most studies 
agreed that, smoking reduced the risk associated with endometrial cancer among 
women at greatest risk, especially obese women or those who use 
postmenopausal hormones (124, 125, 126). However, due to the high number of 
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smoking associated cancers in our study, we do believe that the protective effect of 
was exaggerated.  
 
  5.4. Reproductive factors 
  There is considerable evidence that the reproductive factors play pivotal roles not 
only in the   aetiology of endometrial cancer, but most female cancers. This is 
because most of these factors may directly or indirectly affect the balance of 
estrogen/progesterone levels, and this can lead to a change in an organ's 
exposure to the hormones. The menstrual cycle, number of pregnancies, number 
of miscarriages, age of menarche and age at menopause, and contraceptives use 
are all associated with fluctuating levels of estrogen and progesterone (47, 76, 
131, 132). The following reproductive factors were the focus of our study: 
 
5.4.1. Age at menarche  
 The age of women at menarche and age at menopause is the most frequently 
studied and the most controversial characteristic, not only in relation to endometrial 
cancer, but also with all types of gynaecological cancers (133).  In the current 
study we found a significant relationship between age at menarche and 
endometrial cancer (P<0.05). Our results were paralleling with results from Fujita 
and colleagues who found significant relationship between age at menarche and 
endometrial cancer (133). Similarly, prospective studies indicate that there is a 
reduction in risk of endometrial cancer when menarche takes place at a later age 
(48,76), and this is due to reduction in the overall number of cycles, resulting in 
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less estrogen that may affect the body. Previous case control studies regarding the 
effect of age at menarche on endometrial cancer have been equivocal, with some 
studies showing no definite relationship (134), and others showing a 2-fold 
increased risk of endometrial cancer when menarche occurs at later age (47).  
 
 It has been hypothesised that high energy intake in general could result in an 
increased risk of endometrial cancer, both by producing obesity, lowering the age 
at menarche, and lowering the age maturation (131). Evidence for the latter 
mechanism include the observation that the age of menarche is delayed by 
protein-calorie malnutrition, and tend to occur earlier in better nourished western 
industrialised countries and relatively high socioeconomic groups than in more 
poorly nourished and underdeveloped countries and lower socioeconomic groups. 
 
5.4.2. Age at menopause 
 In the present study, evaluation of the relationship between age at menopause and 
the risk of endometrial cancer showed a significant association only in  univariate 
analyses (4-4), while no such relation existed in multivariate analyses (table 4-4) 
despite the fact that there was a strong association in Chi square tests (P<0.01) 
(table 4-2). These results parallel a previous study, where Brinton and colleagues 
found no association between endometrial risk and age at menopause (47). 
 
 Indeed most recent studies observed a positive relationship between endometrial 
cancer and age at menopause (47, 70, 76). The later age at menopause, the 
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higher risk of endometrial cancer, because higher age means more cycles, that is, 
more exposure to estrogens. In our study the only explanation for our results may 
be due to the fact that our controls also have cancers, and these cancers may 
directly or indirectly affect the menstrual cycle. The cancers may have an indirect 
effect as they occurred mostly around the age of menopause, therefore it might 
have disturbed their menstrual cycles, as menses are affected strongly by the 
psychological status of the woman, and no doubt having cancer lead to 
deterioration in the psychological status.  While the direct effect is due the high 
levels of cytokines that is common in cancer patients and thus affect the 
oestrogen/progesterone levels (76). 
 
5.4.3. Age at first and last live birth 
The present study has detected a significant relationship in the univariate analysis 
(table 4-4) between the risk of endometrial cancer and the age youngest child (age 
of women at last live birth), thus the older the age of youngest child the higher risk 
of endometrial cancer. This relation was consistent in the multivariate analysis, 
while no significant relationship has been noticed between the age of oldest child 
(age of the women at first live birth) and the risk of endometrial cancer in both 
univariate analysis and multivariate analysis. The relationship between the ages of 
oldest and/or youngest child and endometrial cancer may reflect the age of the 
mother at first and last successful delivery and its relation with endometrial cancer. 
Age at first pregnancy does not appear to have any significant relationship with 
endometrial cancer in most studies (47, 49, 67, 68, 69). On the contrary women 
63 
 
who give births relatively late in their reproductive lives have been shown to be at 
lower risk for endometrial cancer than are those who complete their childbearing 
early (70, 69).  
 
 Lesko and colleagues found that delivery after age 40 years was associated with 
as much as a 60 percent reduction in endometrial cancer risk (135). Anovulatory 
cycles are common at both the beginning and the end of reproductive life; their 
occurrence late in reproductive life and the effect on the risk of endometrial cancer 
is of interest here. Because pregnancy is indicative of normal ovulatory function, 
women who deliver late in life can be assumed to be ovulatory late in reproductive 
life (at least up to the time of conception), while women who do not become 
pregnant late may or may not be ovulatory during this period of life. Thus, women 
who have delivered a child late in life are at a lower risk of having anovulatory 
cycles late in reproductive life compared with women who have not had a late 
pregnancy, and therefore may be at lower risk of endometrial cancer. Alternatively, 
late pregnancy itself may confer a direct protective effect on the endometrium (69). 
 
 5.4.4. Number of pregnancies 
 Nulliparity is associated with a two- to threefold increased incidence of endometrial 
cancer. Nulliparity is believed to be related to infertility rather than intentional 
prevention of pregnancy. Infertility related to anovulation and progesterone 
deficiency increases the risk of endometrial cancer, whereas infertility related to 
tubal factors does not (8). In the present study and unlike other studies, we did not 
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find a significant relation between endometrial risk and nulliparity (P>0.05), nor 
have we found any significant differences between having up to seven pregnancies 
and/or not having any pregnancy and the risk of endometrial cancer (8). The small 
number of nulliparous women in our study could be one of the reasons that caused 
the non significant association with endometrial cancer. 
 
5.4.5. Numbers of miscarriages  
 The present study has detected a significant relationship between the occurrence 
of miscarriage and the risk endometrial cancer. Our results were consistent in Chi 
square analysis, univariate analysis, as well as multivariate analysis. The 
relationship between endometrial cancer and miscarriage is still unclear as most 
studies did not find any association (47, 71, 72), although some others suggested 
a protective factor (64, 73, 74, 75). McPherson and colleagues have shown a 
significant relationship between endometrial cancer and numbers of miscarriages, 
but after adjusting for other factors this association no longer exists (76).  
 
 Ending the pregnancy before the age of 22 weeks or miscarriage has been 
reported in some studies to be more related to risk of breast cancer. In early 
pregnancy the level of oestrogens elevates, provoking breast cells to grow in 
preparation for lactation. It has been hypothesised that if this process is interrupted 
with an abortion – before full differentiation in the third trimester then more 
relatively vulnerable undifferentiated cells could be left than there were prior to the 
pregnancy, resulting in a greater potential risk of breast cancer. However, no 
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explanation has been proposed in the literature why miscarriage might increase 
the risk of endometrial cancer (74, 75). 
 
5.4.6. The use of Contraceptives 
 No significant relationship has been found in the present study between the use of 
oral and/or injectable contraceptives and endometrial cancer risk. Other studies 
have reported that contraceptives have a protective effect against endometrial 
cancer, and the use of the combined oral contraceptive pill which contains 
oestrogen and progestogen had reduced the risk of endometrial cancer 
significantly (136, 137, 138). In a study performed in Sweden, Weiderpass et al. 
reported that long-term use of combined oral contraceptives appears to decrease 
the risk more, and the protective effect may continue for 20 years after the woman 
stopped treatment (136).  
 
 
5.5. Other risk factors and endometrial cancer 
 
 5.5.1. Diabetes     
 The relationship between diabetes and endometrial cancer risk was significant in 
univariate analysis (P> 0.05). However, due to considerable number of missing 
data (45.27% of the controls and 56.76% of the cases) this variable has been 
excluded from the multivariate analysis. Brinton and colleagues (1992), have found 
a positive association between being diabetic and the risk of endometrial cancer 
(relative risk 2.0), even after adjusting for weight and other related factors (47). In 
most other studies, no significant relationship has been detected between diabetes 
and endometrial cancer (70, 105, 139, 140, 141, 142).   
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 Diabetes is assumed to be a risk factor for endometrial cancer, although 
epidemiological studies data are controversial as most of the results are not 
consistent. When studies adjusted for body weight, the relationship between 
diabetes either becomes weaker (69, 70) or disappeared (139,140). This is 
because most of type 2 diabetes patients are often obese (131), and studies 
consistently show strong positive associations between body weight and 
endometrial cancer (70). Some other studies demonstrated that this relation is due 
the hyperinsulinaemia, as high levels of insulin may have an etiologic role in 
endometrial cancer independent of body weight and not only with endometrial 
cancer but with other kind of cancer as has been hypothesised for colorectal (143, 
144) and breast (145,146) cancer. Unfortunately, we do not have any information 
regarding the weight of the participants; neither have we had any information to 
state whether or not some of the participants are hyperinsulinemic.  
 
5.5.2. HIV/AIDS 
The inverse significant relationship detected with endometrial cancer, could be due 
the high number of control patients who might have HIV related cancer. The 
percentage of controls that were HIV-positive was more than double to this within 
the cases (table 2 in the appendix). Unlike any other disease HIV-AIDS has been 
associated with extraordinary level of fear, shame, denial and discrimination since 
it was identified. This negative stigma with HIV-AIDS has not only created a 
drawback in any study rely on self report, but also created a barrier in fighting the 
disease. The status of being HIV positive has been reported in several studies to 
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be associated with other kinds of cancer. In addition to the AIDS-defining cancers 
such as non-Hodgkin’s lymphoma, Kaposi’s sarcoma, and cervical cancer, rates of 
Hodgkin’s disease and anal cancer have been reported consistently to be 
associated with HIV/AIDS patients (102, 103, 104). 
 
5.5.3. Hypertension 
The current study showed a significant association between endometrial cancer 
and the history of having hypertension in the univariate analysis (OR=2.94, 95% 
CI: 1.67-5.17). However, due to the considerable number of missing data (40.54 of 
the controls and 53.38% of the cases), this variable has been excluded from the 
multivariate analysis. Hypertension is common in women with endometrial cancer, 
suggesting that it may play some role in the development of the disease (47). 
 
 It has been reported that hypertension may increase the risk of cancer by blocking 
and subsequently modifying apoptosis, thereby affecting the regulation of cell 
differentiation and determination (139, 140). Although hypertension is related to 
being overweight, which in turn is associated with elevated oestrogen levels, 
hyperinsulenimia and high levels of cytokines (106), most studies failed to find 
independent relation between hypertension and endometrial cancer (105). Again 
missing data regarding hypertension in the current study might affect the power of 
the analysis. 
 Brinton and colleagues 1992 have found a significant relation between 
hypertension and endometrial cancer, but this relation has disappeared after 
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adjusting for weight, suggesting no sole relation between endometrial cancer and 
hypertension (47). Unfortunately, we do not have any information regarding the 
weight of the study participants in order to judge whether or not the significant 
relation between hypertension and endometrial cancer is due to weight or solely 
related to the disease.   
 Postmenopausal status, hypertension and obesity could all be considered as risk 
factors for carcinomatous transformation within endometrial polyps in women 
without a history of breast carcinoma with Tamoxifen treatment (147). However, 
our series is small (only six cases considered) and further studies are necessary to 
confirm this hypothesis. 
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 Conclusion 
 
1.  Endometrial cancer was more frequent among women who were older, 
especially after menopause. Women who experienced miscarriages were also 
at higher risk for endometrial cancer. 
  
2. The risk of endometrial cancer was higher in women who complete their 
childbearing earlier in their reproductive lives compared with those who 
completed their child bearing late while no relationship has been found in 
women with a history of infertility. 
 
3. It appears that the amount of oestrogen that a woman is exposed to in her 
lifetime influences her chances of contracting endometrial cancer. Women who 
are exposed to more estrogen, either naturally or from outside sources, are 
more likely to develop endometrial cancer. Thus any factor that causes a 
woman to have high levels of estrogen is also a risk factor for endometrial 
cancer. The more menstrual cycles a woman has in her lifetime, the more 
oestrogen her endometrium is exposed to. Women who started menstruating 
early, and go through menopause late are applicable in this case. 
 
4. There was significant relationship between number of miscarriages and 
endometrial cancer risk, and this relationship was significantly high when 
miscarriages were three times or more. 
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5. This study showed an inverse relationship between smoking and the risk of 
endometrial cancer, and this was not surprising as most studies had showed 
smoking to have a protective effect against endometrial cancer. However, 
comparing the cases of endometrial cancer with smoking-associated cancer 
controls (i.e. lung cancer, oesophageal cancer, and mouth cancer) might have 
an effect. Our suggestion is to compare the cases in such studies with controls 
that had no cancers to finalise the relation between smoking and endometrial 
cancer. 
 
6. The conflict between our study and some previous study results may be due 
to population differences across studies or the way that the study been 
designed. (i.e. the way that the information was collected from the cases and 
controls, source of controls, etc).  
 
7. Because the incidence of endometrial cancer escalates with increasing age, 
this may continue to be future problem as most societies tend to be elderly 
(increasing old people due to low fertility rate). This issue could be less clear in 
the South African black population, but may play a pivotal role in changing the 
incidence of the disease in other races in the future. 
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Appendix 1.1 
 
Table-1- The distribution of endometrial cancer cases and controls, by age group 
among Black South African women, at Johannesburg tertiary hospitals between 1995 
and 2004 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Age (years) Endometrial cancer  cases  
            
No                     % 
     Controls 
 
No                     % 
25-29 1                         0.675 3                       0.675 
30-34 6                         4.054 18                     4.054 
35-39 8                         5.405 24                     5.405 
40-44 8                         5.405 24                     5.405 
45-49 11                       7.432 33                     7.432 
50-54 8                         5.405 24                     5.405  
55-59 22                       14.864 66                    14.864 
60-64 20                       13.513 60                    13.513 
65-69 24                      16.216 72                     16.216    
70-74 19                       12.837 57                     12.837 
75-79 16                       10.81 48                      10.81 
80-84 1                         0.675 3                        0.675   
85-90 4                         2.702 12                       2.702      
Total 148                     100.0 444                    100.0 
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Table-2-The contribution of each cancer in the study among Black South African 
women, at Johannesburg tertiary hospitals between 1995 and 2004 
 
Type of cancer              Freq.      Percent out of the controls % out of the total number 
Tongue cancer 14 3.15 2.36         
Mouth cancer 10 2.25 1.69         
Parotid cancer 4 0.9 0.68         
Esophagus 111 25.00 18.75        
Stomach  21 4.73 3.55        
Colon  14 3.15 2.36        
Rectum 21 4.73 3.55        
Liver  11 4.47 1.86        
Pancreas 5 1.12 0.84        
Maxillary sinus 8 1.80 1.35        
Lung 31 6.98 5.24        
Bone of Skull 7 1.57 1.18        
Bone marrow  63 14.18 10.64        
Skin 44 9.91 7.43        
Sub. tissue 8 1.80 1.35 
Kidney 5 1.12 0.84        
Bladder 6 1.35 1.01        
Thyroid gland 9 2.03 1.52        
Limbs 6 1.35 1.01        
Lymph nodes  33 7.43 5.57        
Other primary sites  13 2.93 2.20       
Endometrial cancer 148 ---------------------------- 25.00        
Total 592  100.00 100.00 
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Table-3- Comparison of demographical factors between cases and controls 
among Black South African women, at Johannesburg tertiary hospitals between 1995 
and 2004 
 
 
 
 
 
 
Variables  Controls  No. Cases  No. P-value 
Total Number 
Age (mean) 
Highest age (years) 
Youngest age (years) 
Standard deviation 
444 
60.30 
90 
27 
13.63 
 148 
60.30 
90 
27 
13.63 
  
Education level 
No schooling 
Grade 1 to grade 4 
Grade 5 to grade 7 
Grade 8 to grade 10 
Grade 11  to grade 12 
University level 
 Missing data 
 
% 71.3 
% 74.6 
% 77.1 
% 79.6 
%  72.5 
%  63.6 
%  0.7 
444 
114 
41 
91 
117 
71 
7 
3 
 
% 28.8 
% 25.5 
% 22.9  
% 20.4 
% 27.6 
% 36.4 
----------  
148 
46 
14 
27 
30 
27 
4 
 
 
 
P= 0.514 
 
Pension  status 
Yes 
No 
Missing data 
 
%   75.6 
%   66.1 
%   77.6 
444 
102 
72 
270 
 
% 24.4  
% 33.9 
% 22.4 
 
148 
33 
37 
78 
 
 
P= 0.052 
Residence status (Urban/Rural) 
Urban areas 
Rural  areas 
Missing data 
 
%  75.7   
%  71.0 
444 
368 
71 
 
%  24.28 
%  29.00 
148 
118 
29 
 
P= 0.546 
Place of birth 
Soweto 
Johannesburg 
Gauteng 
North Province  
Kwazulu Natal 
Free State  
North West  
Mpumalanga   
 
Missing data 
 
%  82.5 
%  83.3 
%  67.8 
%  71.6   
%  78.7 
 %  72.0   
%  81.1   
%  79.1 
 
%100.00   
444 
33 
40 
101 
58 
74 
59 
43 
34 
 
2 
 
% 17.5 
%  16.7 
%  32.2    
%  28.4 
% 21.3 
%  28.1 
%  18.9 
%  20.9 
 
 ------ 
148 
7 
8 
48 
23 
20 
23 
10 
9 
 
---- 
 
 
 
 
 
 
P= 0.181 
 
 
 
Place current residence 
Soweto 
Johannesburg 
Gauteng 
Kwazulu Natal 
Northern province  
Free State  
North West  
 
Missing data 
 
%  80.9 
% 79.0 
%  70   
%  68.8 
%  62.8   
%   72.2 
%  78.8 
 
% 100 
444 
169 
60 
126 
22 
27 
13 
26 
 
1  
 
% 19.1 
% 21.1 
 %  30 
%  31.3 
% 37.2 
%  27.8 
%  21.2 
 
 0.0000 
148 
40 
16 
54 
10 
16 
5 
7 
 
----- 
 
 
 
 
 
P= 0.081 
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Table -4- Comparison of reproductive factors between cases and controls among 
Black South African women, at Johannesburg tertiary hospitals between 1995 and 2004 
 
 
Variables %Controls NO %Cases NO P-value 
Age at Menarche 
Age 11-14 years 
Age 15-18 years 
Age 19-22 years 
Missing data 
 
%  65.5 
% 79.5 
% 79.4 
% 81.8 
444 
127  
272 
27 
18 
 
% 34.5 
% 20.5 
% 20.6 
% 18.2 
148 
67 
70 
7 
4 
 
 
P= 0.003 
Age at Menopause 
Age 30-39 years 
Age 40-45 years 
Age 46-50 years 
Age 51-60 years 
Missing data 
 
% 68.8 
% 79.1 
% 75.5 
% 63.4   
% 85.5  
444 
22 
68 
163 
85 
106   
 
% 31.3 
% 20.9 
% 24.5 
% 36.6 
% 14.5 
148 
10 
18 
53 
49 
18 
 
 
P= 0.001 
Pregnancies 
Yes 
No 
Missing data 
 
% 75.5 
% 68.8 
---------- 
444 
422 
22 
----- 
 
% 24.5 
%  31.3 
% 100.00 
148 
137 
10 
1  
 
P= 0.154 
No of full term pregnancies  
Once 
Twice 
Three times 
Four times 
Five times or more 
Missing data 
 
% 72.0 
% 69.4 
% 71.2 
% 82.1 
% 78.0 
% 62.2 
444 
36 
59 
52 
69 
205 
 23 
 
% 28.0 
% 30.6 
% 28.8 
% 17.9 
% 22.1 
% 37.8 
148 
14 
26 
21 
15 
58 
14 
 
 
 
P= 0.111 
Age of the Child   
1.  oldest child 
Age 2-19  years 
Age 20-37 years 
Age 38-55 years 
Age 56-76 years 
Missing data 
 
2. Youngest child 
Age 1-14  years 
Age 15-28 years 
Age 29-42 years 
Age 43-65 years 
Missing data 
 
 
% 84.8 
% 80.7 
% 76.2 
% 72.5 
% 55.7 
 
 
% 90.7 
% 81.1 
% 77.8 
% 65.0 
% 60.0 
 
444 
39   
121 
211   
29 
44  
 
444 
  68  
 116 
147 
  26   
  87 
 
 
% 15.2 
% 19.3 
% 23.8 
% 27.5 
% 44.3 
 
 
%  9.3 
%  18.9 
%  22.2 
%  35.0 
%  40.0 
 
148 
   7 
29 
66 
11 
35 
 
148 
7 
27 
42 
14 
58 
 
 
 
P= 0.000 
 
 
 
 
 
 
P= 0.000 
Miscarriages 
No miscarriage  
One miscarriage 
Two miscarriages 
Three or more miscarriages 
Missing data  
 
% 80.9 
% 72.0 
% 68.5 
% 51.0 
% 79.1 
444 
161 
85   
37  
25  
136   
 
%  19.1 
%  28.0 
%  31.5 
%  49.0 
%  20.9 
148 
38 
33 
17 
24 
36 
 
 
 
P= 0.000 
Use of contraceptives 
Yes 
No 
Missing data 
Use inject-able contraceptive 
Yes 
No 
Missing data 
 
% 74.4 
% 75.0 
% 100 
 
% 80.3  
% 74.0 
% 100 
444 
61 
381 
2 
444 
57   
382 
5 
 
% 25.6 
% 25.0 
-------- 
 
% 19.7 
%  26.0 
--------- 
148 
21 
127 
-----  
148 
14 
134 
----- 
 
P= 0.711 
 
 
 
P= 0.225 
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Table- 5- Comparison of lifestyle factors between cases and controls among Black 
South African women, at Johannesburg tertiary hospitals between 1995 and 2004 
 
Variables %Controls No %Cases No P-value 
Snuff use 
Current snuffer 
Former snuffer 
Never snuff 
Missing data 
 
% 63.4 
% 82.9 
% 76.4 
% 50.0 
444 
59 
58 
326 
1 
 
% 36.6 
% 17.1 
% 23.7 
% 50.0 
148 
34 
12  
101 
1 
 
 
P= 0.018 
Snuffing frequency 
Snuff  1-4 times daily 
Snuff 5-9 times daily 
Snuff 10-20 times daily 
Missing data 
 
% 67.1 
% 77.8 
% 72.7 
% 76.4 
444 
55 
35 
24 
330 
 
% 32.9 
% 22.2 
% 27.3 
% 23.6 
148 
27   
10  
 9 
102 
 
 
P=  0.325 
Smoking 
Current smoker 
Former smoker 
Never smoke 
Missing data 
 
% 87.3 
% 86.3 
% 71.1 
% 100.00 
444 
55 
69 
318   
2 
 
% 12.7 
% 13.8 
% 28.9 
--------- 
148 
8 
11 
129 
------ 
 
 
P= 0.002 
Age of start smoking 
Age 10-16 
Age 17-24 
Age 25-50 
Missing data 
 
% 88.6 
% 88.4 
% 86.2   
% 71.2 
444 
31 
61 
25 
327   
 
% 11.4 
% 11.6 
% 13.8 
% 28.8 
148 
  4 
  8 
  4 
132 
 
 
P= 0.001 
Age of stop smoking 
Age  15-30 
Age  31-46 
Age  47-62 
Age  63-76 
Missing data 
 
% 72.7 
% 73.3 
% 95.8 
% 83.3  
% 74.0 
444 
 8 
 11 
 23   
 10   
 392   
 
% 27.3 
% 26.7 
% 4.2 
% 16.7 
% 26.0 
148 
3 
4 
1 
2 
138 
 
 
P= 0.174 
 
 
Wine consumption 
Most days 
More than once a week 
Less than once a week 
Never drink 
Missing data 
 
% 75.0 
% 20.0 
% 85.7 
% 71.0 
% 78.7 
444 
12   
1 
12   
179 
240   
 
% 25.0 
% 80.0 
% 14.3 
% 29.0 
% 21.3 
148 
4 
4 
2 
73 
65 
 
 
P= 0.010 
Maize Beer consumption  
Most days 
More than once a week 
Less than once a week 
Never drink 
Missing data 
 
% 72.2 
% 77.3 
% 60.4  
% 72.4  
% 79.0    
444 
13 
17 
29 
144 
241 
 
% 27.8 
% 22.7 
% 39.6 
% 27.6 
% 21.0 
148 
5 
5 
19 
55 
64 
 
 
P= 0.063 
Diabetes 
Yes 
No 
Missing data 
   
% 81.0 
% 60.7 
% 70.5  
 
226 
17 
201 
 
% 19.0 
% 39.3 
% 29.5  
 
53 
11 
84 
 
P= 0.003 
HIV 
Yes 
No 
Missing  data 
 
% 87.0 
% 75.3 
% 64.3 
 
47 
350 
47   
 
%12.9 
% 24.7 
% 35.6 
148 
7 
115 
26 
P= 0.014 
Hypertension 
Yes 
No 
Only during pregnancy 
Missing data 
 
% 69.4 
% 87.0 
% 100.0 
% 69.5 
 
102 
161 
1 
180   
 
% 30.6 
% 13.0 
---------- 
 30.5 
 
45 
24 
0 
79 
 
P= 0.000 
90 
 
 
1. 2. Staging of endometrial cancer 
Most endometrial cancers are staged according to a surgical system approved in 
1988 by the International Federation of Gynecology and Obstetrics. Factors used 
to stage the disease include the depth of the tumor, whether the tumor has 
spread to the cervix and other nearby organs, the cytology of the cancer (cellular 
make-up and activity), whether it has metastasized to the lymph nodes, and the 
extent to which it has spread to other parts of the body. Endometrial cancer in 
patients, who are unable to undergo surgical evaluation, is staged using an older, 
clinical staging system.  
 
Table -6- FIGO’s Surgical Stages for Endometrial Cancer (147).  
Stage I The tumor is confined to the uterine fundus (the body of the uterus). 
 Survival rate is about 90% to 95%. 
Stage IA The tumor is limited to the endometrium (the lining of the uterus), and no 
myometrial invasion. 
Stage IB The tumor invades less than one-half of the myometrial thickness (the 
myometrium is the muscular tissue that is found just beneath the 
endometrium), %50 myometrial invasion. 
Stage IC The tumor invades more than one-half of the myometrial thickness. 
Stage II The tumor extends to the lower part of the uterus (the corpus and the 
cervix). Survival rate is about 75%. 
Stage IIA Cervical extension is limited to the endocervical glands; glands in the 
inner lining of the uterus, where the cervix meets the uterus (endocrine 
glandular involvement). 
Stage IIB Tumor invades the cervical stroma (the supporting connective tissue of 
the cervix). Cervical stromal involvement. 
Stage III There is regional tumor spread. Survival rate is about 60%. 
Stage IIIA  The tumor invades the uterine serosa (the layer of tissue that surrounds 
the outside of the uterus), or adnexa (tissues on either side of the uterus), 
or cells in the peritoneum (the member surrounding the abdominal cavity) 
show signs of cancer. 
Stage IIIB Vaginal metastases are present. 
Stage IIIC The tumor has spread to lymph nodes near the uterus. 
Stage IV There is bulky pelvic disease or distant spread (intraabdomenal 
metastasis, extra abdominal metastasis, and/ or involvement of the lamph 
nodes).  Survival rate is about 15% to 26%. 
Stage IVA Tumor has spread to the bladder or rectum. 
Stage IVB Distant metastases are present. 
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